JohnG.QuigleyMD

Oncology • Chicago, IL

Hematologic Oncology

University of Illinois at Chicago

Join to view full profile

Dr. Quigley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Quigley's full profile

Already have an account?

Office
1740 W Taylor St
Chicago, IL 60612
Phone+1 866-600-2273
Is this information wrong?

Education & Training

University College of Dublin National Univ SOMClass of 1986

Certifications & Licensure

IL State Medical License 2004 - 2026

Clinical Trials

Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Dec 14
Completed
Phase 2
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Active, not recruiting
Phase 3
AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients Start of enrollment: 2015 Jun 05
Terminated
Phase 1, Phase 2
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 Start of enrollment: 2019 Sep 06
Active, not recruiting
Phase 1
Roles: Sponsor-Investigator, Contact, Principal Investigator
Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Completed
Phase 2, Phase 3
Roles: Contact
Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) Start of enrollment: 2022 Jun 21
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protopor...
Cynthia Levy, Amy K Dickey, Bruce Wang, Manish Thapar, Hetanshi Naik, Siobán B Keel, Behnam Saberi, Simon W Beaven, Sean R Rudnick, Sarina B Elmariah, Angelika L Erwin...> ;Hepatology. 2024 Mar 1
3 citations
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
Jeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, Michelle N Gong, Harmony R Reynolds, Mary Cushman, Andrew D Althouse, Patrick R Lawler, Bryan J McVerry, Keri S Kim...> ;JAMA Network Open. 2023 May 1
7 citations
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Tracy Y Wang, Abdus S Wahed, Alison Morris, Lisa Baumann Kreuziger, John G Quigley, Gervasio A Lamas, Alexandra J Weissman, Jose Lopez-Sendon, M Margaret Knudson, Debo...> ;Annals of Internal Medicine. 2023 Apr 1
6 citations
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design.
Chu, H. Y., Leora I Horwitz, Tanayott Thaweethai, Shari B Brosnahan, Mine S Cicek, Megan L Fitzgerald, Jason D Goldman, Rachel Hess, S L Hodder, Vanessa L Jacoby, Mich...> ;Plos One. 2023 Jan 1
5 citations
Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria.
Amy K Dickey, Hetanshi Naik, Siobán B Keel, Cynthia Levy, Simon W Beaven, Sarina B Elmariah, Angelika L Erwin, Robert J Goddu, Karli Hedstrom, Rebecca K Leaf, Mohamed ...> ;Journal of the American Academy of Dermatology. 2023 Dec 1
31 citations
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes.
Abraham, I., Rauscher, G., Patel, A., Pearse, W., Rajakumar, P., Burkart, M., Aleem, A., Dave, A., Bharadwaj, S., Paydary, K., Acevedo-Mendez, M., Goparaju, K., Gomez,...> ;Blood. 2022 Apr 7
1 citations
Omacetaxine added to a standard acute myeloid leukaemia chemotherapy regimen reduces cellular FLIP levels, markedly increasing the incidence of eccrine hidradenitis
Jonwei Hwang, Naina Singh, Marylee Braniecki, Betul Gok Yavuz, Maria M. Tsoukas, John G. Quigley> ;British Journal of Haematology. 2021 Sep 7
3 citations
Correction to: Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.
Mohamed Kazamel, Robert J. Desnick, John G. Quigley> ;Current Neurology and Neuroscience Reports. 2021 Jan 1
16 citations
Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.
Mohamed Kazamel, Robert J. Desnick, John G. Quigley> ;Current Neurology and Neuroscience Reports. 2020 Oct 7
2 citations
A multi‐institutional comparison of mitoxantrone, etoposide, and cytarabine vs high‐dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory a...
Sonia Christian, Saad Arain, Pritesh R. Patel, Irum Khan, Gregory S. Calip, Vaibhav Agrawal, Karen Sweiss, Shawn Griffin, Kirk E. Cahill, Heiko Konig, Aysenur Esen, Ar...> ;American Journal of Hematology. 2020 Apr 20
7 citations
A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities
Nupur Mittal, Jonathan Davidson, Mario F Martinez, Reynaldo Sanchez, Nitin Sane, Lisa Giordano, Daniel K. Choi, Paul Kent, Asneha Iqbal, Cathleen Kiely, Kathleen Breen...> ;Journal of Adolescent and Young Adult Oncology. 2019 Jun 4
15 citations
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma.
Gregory S. Calip, Kellyn M. Moran, Karen Sweiss, Pritesh R. Patel, Zhaoju Wu, Sruthi Adimadhyam, Todd A. Lee, Naomi Y. Ko, John G. Quigley, Brian C.-H. Chiu> ;Cancer. 2019 Apr 1
7 citations
A novel drug interaction between busulfan and blinatumomab.
Karen Sweiss, John G. Quigley, Annie Oh, Jonathan Lee, Rosa Ye, Damiano Rondelli, Pritesh R. Patel> ;Journal of Oncology Pharmacy Practice. 2019 Jan 1
41 citations
Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
Santosh L. Saraf, Annie L. Oh, Pritesh R. Patel, Karen Sweiss, Sally Campbell-Lee, Michel Gowhari, Shivi Jain, David Peace, John G. Quigley, Irum Khan, Robert E. Molok...> ;Biology of Blood and Marrow Transplantation. 2018 Aug 1
12 citations
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory mu...
Pritesh R. Patel, Annie L. Oh, Karen Sweiss, Santosh L. Saraf, John G. Quigley, Irum Khan, Nadim Mahmud, Eileen Hacker, Howard Ozer, David Peace, Ralph R. Weichselbaum...> ;Leukemia & Lymphoma. 2018 Jul 1
12 citations
miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3.
Yunyuan Zhang, Liping Li, Chunjie Yu, Vitalyi Senyuk, Fuxing Li, John G. Quigley, Tongyu Zhu, Zhijian Qian> ;Scientific Reports. 2018 Apr 25
9 citations
A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant
Karen Sweiss, Jennifer L. Anderson, Scott Wirth, Annie Oh, John G. Quigley, Irum Khan, Santosh L. Saraf, Christina Mactal-Haaf, Damiano Rondelli, Pritesh R. Patel> ;Bone Marrow Transplantation. 2018 Mar 1
3 citations
Spinal cord and cranial Bing-Neel Syndrome complicated by cerebral ischemia: A case report.
Alejandro Vargas, Karan Dixit, John G. Quigley, Fernando D. Testai> ;Journal of the Neurological Sciences. 2016 Jul 15
9 citations
Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms.
Irum Khan, Ardaman Shergill, Santosh L. Saraf, Yi Fan Chen, Pritesh R. Patel, John G. Quigley, David Peace, Victor R. Gordeuk, Ronald Hoffman, Damiano Rondelli> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Jun 1
92 citations
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
, , , , , , , , , , , , , , , , , , > ;Biology of Blood and Marrow Transplantation. 2016 Mar 1
19 citations
A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease
Igor A. Altman, Raymond E Kleinfelder, John G. Quigley, William J. Ennis, Caterina P. Minniti> ;International Wound Journal. 2016 Dec 1
52 citations
The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells
Yu Hou, Wen Li, Yue Sheng, Liping Li, Yong Huang, Zhonghui Zhang, Tongyu Zhu, David Peace, John G. Quigley, Wen Shu Wu, You Yang Zhao, Zhijian Qian> ;Nature Immunology. 2015 Aug 1
31 citations
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.
Pritesh R. Patel, Bulent Aydogan, Dolores Mahmud, Annie Oh, Santosh L. Saraf, John G. Quigley, Irum Khan, Karen Sweiss, Nadim Mahmud, David Peace, Vincenzo DeMasi, Azh...> ;Biology of Blood and Marrow Transplantation. 2014 Dec 1
36 citations
Differential Effects of Epigenetic Modifiers on the Expansion and Maintenance of Human Cord Blood Stem/Progenitor Cells
Nadim Mahmud, Benjamin Petro, Sudhakar Baluchamy, Xinmin Li, Simona Taioli, Donald Lavelle, John G. Quigley, Montha Suphangul, Hiroto Araki> ;Biology of Blood and Marrow Transplantation. 2014 Apr 1
The Concise Guide to PHARMACOLOGY 2013/14: overview.
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ, Abul-Hasn N, Anderson CM, Anderson CMH, Araiks...> ;Br. J. Pharmacol.. 2013-12-01
Join now to see all